Table III.
Protein expression of LGALS1 and pathological features in patients with ovarian cancer.
| LGALS1 expression | ||||
|---|---|---|---|---|
|
|
||||
| Characteristics | No. (%) | Positive cases (%) | Negative cases (%) | P-value |
| Age, years | ||||
| <55 | 21 (48.84) | 10 (47.62) | 11 (52.38) | 0.290 |
| ≥55 | 22 (51.16) | 14 (63.64) | 8 (36.36) | |
| Grade | ||||
| Low grade | 15 (34.88) | 5 (33.33) | 10 (66.67) | 0.030a |
| High grade | 28 (65.12) | 19 (67.86) | 9 (32.14) | |
| Stage | ||||
| I+II | 17 (39.53) | 5 (29.41) | 12 (70.59) | 0.005b |
| III+IV | 26 (60.47) | 19 (73.08) | 7 (26.92) | |
| Lymphatic metastasis | ||||
| Yes | 17 (39.53) | 7 (41.18) | 10 (58.82) | 0.118 |
| No | 26 (60.47) | 17 (65.38) | 9 (34.62) | |
a
P<0.05,
b
P<0.01. χ2 test was used. LGALS1, galectin-1.